PATENT CLAIM ANALYSIS

Application Number: 16270837
Application Type: Utility
Filing Date: 2019-02
Publication Date: 2019-06
Patent Classification: ["424", "494000"]

Abstract:
The present invention provides a simple and improved dose form that is capable of providing a controlled release of GABA B  receptor agonist contained in the core thereof. The invention also provides methods of administering the dosage form and of treating conditions that are therapeutically responsive to GABA B  receptor agonist.

Claim (Index 12):
The method of  claim 11 , wherein said dosage form provides a Cmax and AUC for ARBAC that is lower than that provided by an immediate release dosage form comprising racemic baclofen but the same molar amount of ARBAC and still provides substantially the same or an improved clinical benefit over the immediate release dosage form.

Metadata:
- Claim Count in Document: 113.0
- Percentile: 99.0
- Lexical Diversity: 1.43243
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15146525', '15919422', '15048743', '15919436', '15132972']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8431322748743628
- 35 USC 102 Novelty (BERT): 0.6567508812421733
- Combined Prediction Score: 0.8244941355111438
- Mean Citation Score: 576.303538
- Max Citation Score: 585.8544
- Similarity Product: 572.9042407264709

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test